Financials

  • Market Capitalization 685.11 M
  • Employee 22
  • Founded 2014
  • CEO N/A
  • Website www.monopartx.com
  • Headquarter Delaware, United States
  • FIGI BBG00J7K8D90
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-35.28
Relación precio/flujo de caja

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
2675
AURA
Aura Biosciences, Inc. - Common Stock
6.95 USD-0.71%-0.43%+7.25%+2.21%718.54 M USD
2688
CADL
Candel Therapeutics, Inc. - Common Stock
9.85 USD+2.18%0.00%+13.22%+51.54%721.71 M USD
2711
BBOT
BridgeBio Oncology Therapeutics, Inc. - Common Stock
8.46 USD-0.70%+1.56%+8.46%-10.85%677.71 M USD
2718
RLMD
Relmada Therapeutics, Inc. - Common Stock
6.54 USD+1.40%+7.04%-1.95%+972.13%685.98 M USD

Noticias